ライフサイエンスコーパス: hypopituitarism

1 nd TSH and a relatively rapid development of hypopituitarism.

2 requires hormone replacement for persistent hypopituitarism.

3 nsity in hypogonadal men, including men with hypopituitarism.

4 (21.1%) commenced hormone replacement(s) for hypopituitarism.

5 obstructive lung disease, other cancers, and hypopituitarism.

6 is still developmentally delayed and now has hypopituitarism.

7 with AM, sometimes with poly/syndactyly and hypopituitarism.

8 ound visual loss, ocular motor deficits, and hypopituitarism.

9 nd specific-cause mortality in patients with hypopituitarism.

10 dary to chronic malnutrition, and idiopathic hypopituitarism.

11 the predictable but slowly evolving forms of hypopituitarism.

12 g cytotoxic drugs do not often develop overt hypopituitarism, although the effect of radiotherapy mig

13 s, visual complications, diabetes insipidus, hypopituitarism and cranial nerve injury.

14 ranscription factor SOX3 are associated with hypopituitarism and mental retardation, but nothing is k

15 ologists dealing with patients who have both hypopituitarism and neurological diseases.

16 ssive neurological abnormalities, congenital hypopituitarism and post-retinal visual pathway dysfunct

17 Mass effects cause headache, hypopituitarism, and visual field defects.

18 sed morbidity and mortality in patients with hypopituitarism; availability of highly efficacious, eas

19 Congenital hypopituitarism (CH) is characterized by the deficiency

20 uitary gland in humans results in congenital hypopituitarism (CH).

21 ients) in those given pembrolizumab 2 mg/kg; hypopituitarism, colitis, diarrhoea, decreased appetite,

22 Patients with hypopituitarism develop a phenotype similar to metabolic

23 p 1014 UK patients (514 men, 500 women) with hypopituitarism from January, 1992, to January, 2000.

24 sed from the HypoCCS database of adults with hypopituitarism from the USA, Canada, Japan, and 14 Euro

25 Patients with hypopituitarism have complex endocrine deficiencies, and

26 Patients with hypopituitarism have excess mortality, predominantly fro

27 FOXA2 in a complex congenital syndrome with hypopituitarism, hyperinsulinism and endoderm-derived or

28 to examine the clinical associations between hypopituitarism, hypothalamic dysfunction, and nonalcoho

29 ts seen at our institution with diagnoses of hypopituitarism, hypothalamic obesity, or craniopharyngi

30 MRI are sensitive and specific indicators of hypopituitarism in children with ONH.

31 resonance imaging (MRI) for the detection of hypopituitarism in children with ONH.

32 It is essential to identify hypopituitarism in children with optic nerve hypoplasia

33 2 (SOX2) haploinsufficiency causes a form of hypopituitarism in humans that is characterized by gonad

34 ations in PROP1 are the most common cause of hypopituitarism in humans; therefore, unraveling its mec

35 Hypopituitarism is associated with excess mortality, a k

36 The severity and rate of development of hypopituitarism is determined by the dose of radiotherap

37 Hypopituitarism is diagnosed based on baseline blood sam

38 ;Hesx1Cre/+ compound embryos indicates that hypopituitarism is the likely cause of these defects sin

39 roidism, hyperthyroidism, thyroid neoplasms, hypopituitarism, obesity, diabetes mellitus, or gonadal

40 onsiderable morbidity due to local invasion, hypopituitarism, or hormone hypersecretion.

41 ne supplementation in adrenal insufficiency, hypopituitarism, osteoporosis, systemic lupus erythemato

42 Post-traumatic hypopituitarism (PTHP) can have major consequences for p

43 Hypopituitarism refers to deficiency of one or more horm

44 abnormalities in 27 of the 28 children with hypopituitarism (sensitivity, 96%).

45 cancer can cause autoimmune hypophysitis and hypopituitarism; therefore, oncologists and endocrinolog

46 of second-generation antiepileptic drugs on hypopituitarism treatment.

47 ion of the pituitary gland causes iatrogenic hypopituitarism which requires lifelong hormonal supplem

48 eported premature mortality in patients with hypopituitarism with standard mortality ratios (SMRs) va

49 An additional phenotype of hypopituitarism, with anterior pituitary hypoplasia and

50 fective anterior pituitary formation and pan-hypopituitarism, with or without overt forebrain cleavag